Resources | MediMergent
AZ Study Logo -small

EIMPRIS Clinical Trials Management Dashboard

Resource Library

Drug Fact Sheets

     Evusheld™ Fact Sheet for Healthcare Providers
     Evusheld™ Fact Sheet for Patients
     EUA 104 AZ Evusheld™

Lab / Pharmacy Procedures

     EIMPRIS Pharmacy Manual 
     Lab Manual for the Management of Lab Samples

MediMergent Communication Memos

     Memo 1 –  May 26, 2022
     Memo 2 – June 15, 2022
     Memo 3 – July 11, 2022
     Memo 4 – July 28, 2022
     Memo 5 – August 5, 2022
     Memo 6 – August 8, 2022
     Memo 7 – August 11, 2022
     Memo 8 – August 30, 2022
     Memo 9 – September 7, 2022
     Memo 10 – December 14, 2022

Publications

     Tixagevimab/Cilgavimab for Prevention of COVID-19 during Omicron Surge
     The unmet needs of immunocompromised patients post-COVID 19

Regulatory

     Authorization for the Transfer of Medical Information (English Version) (Spanish Version)
     Extension of the Expiration Date for COVID Home Tests
     Study Protocol – September 7, 2022
     Regulatory Document Portal: Instructions for Uploading
     Read and Confirm Training Document
     MediMergent Training Log – Multiple people

Study Logs/forms

     Temperature Excursion Form 
     Investigational Product Accountability Log
     Delegation of Responsibilities Log
     AE/SAE Reporting Form   
     “Worksheets”
         ESR 22-21698 Inclusion and Exclusion Criteria Worksheet
         ESR 22-21698 Study Worksheet – January 20, 2023

Study supplies

     All purpose Labels
     Initial supply inventory (packing slip)
     Order Form for Drug and Study Supplies
     Chrome Book Operation and startup

Surveys

     Baseline (English Version) (Spanish Version)
     Day 2 (English Version) (Spanish Version) 
     Follow-up (English Version) (Spanish Version) 
     QOL (English Version) (Spanish Version) 

Training materials

     Access Online Training
     EIMPRIS Isoplexis Video
    

Study Contact Directory

FAQ